Skip to main content
. Author manuscript; available in PMC: 2015 Apr 1.
Published in final edited form as: Thorax. 2013 Nov 20;69(4):335–345. doi: 10.1136/thoraxjnl-2013-204324

Figure 6.

Figure 6

Intranasal treatment of peptide 26 (p26) is associated with increased expression of regulatory genes and decreased expression of T helper 2 inflammatory genes. Mice were treated intranasally with phosphate-buffered saline (PBS) (n=6) or p26 (n=6) before footpad immunisation and in vitro p26 stimulation of draining lymph node (DLN) cells. (A) A heat map shows the key genes differentially expressed following in vitro p26 stimulation of DLN cells where fold change is greater than ±1.4 with a p value of <0.05 by analysis of variance. (B) Fold change values and p values for each of these differentially expressed genes are shown.